Your browser doesn't support javascript.
loading
Nivolumab in previously untreated melanoma without BRAF mutation.
Robert, Caroline; Long, Georgina V; Brady, Benjamin; Dutriaux, Caroline; Maio, Michele; Mortier, Laurent; Hassel, Jessica C; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J; Hernberg, Micaela M; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Arance, Ana; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Lundgren-Eriksson, Lotta; Horak, Christine; Sharkey, Brian; Waxman, Ian M; Atkinson, Victoria; Ascierto, Paolo A.
Affiliation
  • Robert C; The authors' affiliations are listed in the Appendix.
N Engl J Med ; 372(4): 320-30, 2015 Jan 22.
Article in En | MEDLINE | ID: mdl-25399552
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dacarbazine / Programmed Cell Death 1 Receptor / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dacarbazine / Programmed Cell Death 1 Receptor / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2015 Type: Article